Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer.

Cancer research·2026
Same author

Clinical-Pharmacological Drug Information Center of Hannover Medical School: Update From a Tertiary Care University Hospital (2022-2024).

Pharmacology research & perspectives·2026
Same author

Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection.

Cancer biology & medicine·2026
Same author

Parkinson's Disease Patient-Specific Striatum Organoids Show Hallmarks of Increased Inflammation.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction.

The New England journal of medicine·2025
Same author

Lactate signalling leads to aggregation of immune-inflammatory hotspots and SLC5A12 blockade promotes their resolution.

Nature metabolism·2025

Related Experiment Video

Updated: Jun 21, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Oncoproteomic profiling with antibody microarrays.

Mohamed Ss Alhamdani1, Christoph Schröder, Jörg D Hoheisel

  • 1Division of Functional Genome Analysis, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany. m.alhamdani@dkfz-heidelberg.de.

Genome Medicine
|July 14, 2009
PubMed
Summary

Cancer biomarkers are crucial for early detection and intervention. Antibody microarrays offer a powerful proteomic tool for advancing cancer research, diagnosis, and monitoring disease progression.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Related Experiment Videos

Last Updated: Jun 21, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
15:17

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Area of Science:

  • Proteomics
  • Oncoproteomics
  • Biomarker Discovery

Background:

  • Global cancer incidence and mortality are rising, necessitating improved diagnostic and intervention strategies.
  • Proteomic exploration is a key focus in cancer research for identifying novel biomarkers.
  • Antibody microarrays are emerging as vital tools in proteomic analysis for cancer studies.

Purpose of the Study:

  • To review the technical aspects and challenges of antibody microarray assay development and application.
  • To examine recent advancements and applications of antibody microarrays in oncoproteomics.
  • To highlight the role of antibody microarrays in cancer early detection and disease monitoring.

Main Methods:

  • Review of technical considerations in antibody microarray design and validation.
  • Analysis of current literature on antibody microarray applications in cancer research.
  • Examination of case studies in oncoproteomics utilizing antibody microarrays.

Main Results:

  • Antibody microarrays provide a high-throughput platform for proteomic profiling.
  • These assays are instrumental in identifying potential cancer biomarkers.
  • Recent applications demonstrate utility in tumor discrimination and disease progression monitoring.

Conclusions:

  • Antibody microarrays are a significant technology for advancing oncoproteomics.
  • Addressing technical challenges is key to maximizing their potential in cancer diagnostics.
  • Continued development and application of antibody microarrays will enhance early cancer detection and patient management.